Research, Patents, Publications

GNC in collaboration with Nichi In Centre for Regenerative Medicine (NCRM) has been working on cell based therapies and tissue engineering systems and has developed novel cell therapy solutions in several specialties; including ophthalmology, urology and orthopaedics.

One of our core strengths has been the possession of technology (both materials and methodologies) for processing, expanding and preservation of stem cells, precursor cells as well as mature cells. With our expertise with a range of biomaterials such as polymer scaffolds and nanocomposite gels, advantageous cell culture and tissue engineering are feasible without animal protein contamination.

Publications

R&D

1．“Surgically maneuverable Technically Advanced, Rejection-free Material for Implant made of Nano-composite”

STAR-MING ; A Breakthrough bio-inert implant for cosmetology. Nine-year case study presented in JAAM meeting 2021. Can be cut into any shape by the surgeon on the table, giving freedom to insert through a smaller incision and position appropriately. While compressible, returns to original shape immediately; Clinical studies under planning. Click here for more details.

2．“Gel film for corneal endothelial cell defect treatment” 

Obtained a patent for gel film for culturing corneal endothelial cells for use in the treatment of defective corneal endothelial cells. Once this treatment is established, a mission to save “An-eye for Eyes” will be possible. This gel film is also patented in India. (www.cesbank.org)